Clinical Trial Update: Paliperidone Extended Release(ER) Effectiveness Study to Evaluate the Objective Symptom Change and Symptomatic Remission [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the effectiveness of Paliperidone Extended Release in schizophrenia with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Paliperidone Extended Release (paliperidone extended-release)

Snippet

Sponsor: Janssen Korea, Ltd., Korea | Conditions: Schizophrenia | Phase 4 | Status: COMPLETED | Results posted: 2014-06-03